CCME Global

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE194N01016
NSEID:
BSEID: 514336
View on BSE

INR

103.74

4.94 (5.0%)

BSENSE

Apr 24

BSE+NSE Vol: 5.39 k

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Amanta Healthcar

Haleos Labs Limi

Jenburkt Pharma

CCME Global

Albert David

Kilitch Drugs

Medicamen Biotec

Valiant Laborato

Zim Laboratories

Solara Active PP

Influx Health.

Why is CCME Global Ltd ?

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.64
The company has been able to generate a Return on Equity (avg) of 9.30% signifying low profitability per unit of shareholders funds

Flat results in Dec 25

NO KEY NEGATIVE TRIGGERS

With ROE of 41.9, it has a Very Expensive valuation with a 53.5 Price to Book Value

Over the past year, while the stock has generated a return of 465.65%, its profits have fallen by 0%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is CCME Global for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

CCME Global

465.65%

7.54

61.73%

Sensex

-4.07%

-0.30

13.37%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0.00%

EBIT Growth (5y)

0.00%

EBIT to Interest (avg)

0.64

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.01

Sales to Capital Employed (avg)

0.02

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

-1.28%

ROE (avg)

9.30%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

128

Industry P/E

Price to Book Value

53.54

EV to EBIT

127.35

EV to EBITDA

127.35

EV to Capital Employed

54.05

EV to Sales

121.80

PEG Ratio

Dividend Yield

ROCE (Latest)

42.44%

ROE (Latest)

41.92%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Loading Valuation Snapshot...